Javascript must be enabled to continue!
Monthly mortality from Alzheimer’s disease and other dementia in Japan
View through CrossRef
AbstractBackgroundThe aim of this study is to research seasonal changes in dementia mortality in Japan and to pursue the excess death on COVID‐19. COVID‐19 excess mortality were higher in homes providing nursing services to older people with dementia in England by Marciano, 2021. We have been researched the temperature‐mortality associations. The optimum temperature with the lowest mortality rate is the 84th percentile of the maximum temperature. We compared the changes in monthly mortality between 2019 and 2020, and examined whether there is an indirect effect on dementia associated with COVID‐19, considering the effects of temperature so far. For comparison, the total deaths of the elderly and accidental deaths such as falls were used.MethodFrom the monthly death from dementia (G30, Alzheimer disease, F01‐03, Vascular Dementia and Other) extracted from the vital statistics in Japan from 2019 to 2020, the dementia mortality rate by sex‐age group aged 65 and over was obtained. We estimated excess mortality using estimates from the optimal curves of monthly temperatures and monthly mortality rates for NCD since 2001, which the author has already announced.ResultSeasonal changes in dementia in 2019‐2020 were assessed to be consistent with estimates from optimal curves for monthly temperature and mortality. However, the 2020 mortality by gender‐age‐class based on 2019 increased sharply in June, August and October for ages 65‐69 and in October (10.2‐43.8 percent) for ages 70‐74. From May to August, falls and traffic accidents decreased, the total mortality of the elderly excluding accidents decreased during the same period, and the mortality of aged 70 and over increased by 8 percent after October. Discussion: The effect of COVID‐19 on dementia in 2020 could not be detected. Since the number of clusters of geriatric medical facilities in Japan has increased significantly since January 2021, long‐term inactivity of physical activity as a factor of immune function decline may increase the mortality from dementia. There are limits based on vital statistics.ConclusionExcess mortality from Dementia was undetectable in 2020, but an increased mortality was observed in certain age groups after the autumn.
Title: Monthly mortality from Alzheimer’s disease and other dementia in Japan
Description:
AbstractBackgroundThe aim of this study is to research seasonal changes in dementia mortality in Japan and to pursue the excess death on COVID‐19.
COVID‐19 excess mortality were higher in homes providing nursing services to older people with dementia in England by Marciano, 2021.
We have been researched the temperature‐mortality associations.
The optimum temperature with the lowest mortality rate is the 84th percentile of the maximum temperature.
We compared the changes in monthly mortality between 2019 and 2020, and examined whether there is an indirect effect on dementia associated with COVID‐19, considering the effects of temperature so far.
For comparison, the total deaths of the elderly and accidental deaths such as falls were used.
MethodFrom the monthly death from dementia (G30, Alzheimer disease, F01‐03, Vascular Dementia and Other) extracted from the vital statistics in Japan from 2019 to 2020, the dementia mortality rate by sex‐age group aged 65 and over was obtained.
We estimated excess mortality using estimates from the optimal curves of monthly temperatures and monthly mortality rates for NCD since 2001, which the author has already announced.
ResultSeasonal changes in dementia in 2019‐2020 were assessed to be consistent with estimates from optimal curves for monthly temperature and mortality.
However, the 2020 mortality by gender‐age‐class based on 2019 increased sharply in June, August and October for ages 65‐69 and in October (10.
2‐43.
8 percent) for ages 70‐74.
From May to August, falls and traffic accidents decreased, the total mortality of the elderly excluding accidents decreased during the same period, and the mortality of aged 70 and over increased by 8 percent after October.
Discussion: The effect of COVID‐19 on dementia in 2020 could not be detected.
Since the number of clusters of geriatric medical facilities in Japan has increased significantly since January 2021, long‐term inactivity of physical activity as a factor of immune function decline may increase the mortality from dementia.
There are limits based on vital statistics.
ConclusionExcess mortality from Dementia was undetectable in 2020, but an increased mortality was observed in certain age groups after the autumn.
Related Results
Imaging breakthroughs in dementia: Pioneering 3D T1-weighted MPRAGE vs. routine spin echo with a focus on Alzheimer's disease
Imaging breakthroughs in dementia: Pioneering 3D T1-weighted MPRAGE vs. routine spin echo with a focus on Alzheimer's disease
Background. Dementia, a spectrum of neurocognitive disorders, leads to progressive cognitive and functional decline, primarily affecting memory and executive functions. Among the m...
Race, polygenic risk and their association with incident dementia among older US adults
Race, polygenic risk and their association with incident dementia among older US adults
AbstractDementia incidence increases steadily with age at rates that may vary across racial groups. This racial disparity may be attributable to polygenic risk, as well as lifestyl...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Understanding the knowledge and attitudes to dementia in Sub‐Saharan Africa: A systematic review
Understanding the knowledge and attitudes to dementia in Sub‐Saharan Africa: A systematic review
AbstractBackgroundA direct result of an ageing population is an increase in the prevalence of chronic non‐communicable diseases such as dementia. Creating dementia awareness and pr...
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
MBI‐apathy, ApoEɛ2, and risk for Alzheimer disease dementia
AbstractBackgroundApathy, characterized by decreased interest, initiative, and emotional reactivity, is amongst the most common neuropsychiatric symptoms in dementia. However, apat...
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Penerapan Metode Convolutional Neural Network untuk Diagnosa Penyakit Alzheimer
Abstract— Alzheimer's disease is a neurodegenerative disease that develops gradually, and is associated with cardiovascular and cerebrovascular problems. Alzheimer's is a serious d...
Dementia Subtypes: A Study From Dementia Clinic In A Referral Neuroscience Hospital, Bangladesh
Dementia Subtypes: A Study From Dementia Clinic In A Referral Neuroscience Hospital, Bangladesh
Background: Dementia is one of the major causes of disability and dependency among older people globally but still it is not explored very well in most parts of the world particula...
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Prescription Patterns of Anti-dementia and Psychotropic Drugs in People Living With Dementia in China
Abstract
Pharmacotherapy of dementia is a critical intervention for managing symptoms of and slowing progression of dementia. However, evidence on prescribing patter...

